Merit Medical Systems 관리
관리 기준 확인 3/4
Merit Medical Systems CEO는 Fred Lampropoulos, Jul1987 에 임명되었습니다 의 임기는 37.33 년입니다. 총 연간 보상은 $ 10.05M, 18.8% 로 구성됩니다. 18.8% 급여 및 81.2% 보너스(회사 주식 및 옵션 포함). 는 $ 119.70M 가치에 해당하는 회사 주식의 1.97% 직접 소유합니다. 119.70M. 경영진과 이사회의 평균 재임 기간은 각각 5.2 년과 4.8 년입니다.
주요 정보
Fred Lampropoulos
최고 경영자
US$10.1m
총 보상
| CEO 급여 비율 | 18.8% |
| CEO 임기 | 37.3yrs |
| CEO 소유권 | 2.0% |
| 경영진 평균 재임 기간 | 5.2yrs |
| 이사회 평균 재임 기간 | 4.8yrs |
최근 관리 업데이트
Recent updates
Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02
Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Nov 01Merit Medical Systems - Impressive Momentum
Sep 17The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Sep 17Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Sep 04Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
Aug 22These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Jul 31Merit Medical Systems: Steady Wins The Day
Jul 05Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth
Jun 19Merit Medical: Undervalued With Multiple Growth Drivers In Play
Jun 15Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
May 23It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package
May 09Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?
Apr 30Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing
Apr 16When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Apr 02Merit Medical Systems: Solid Performer, Fully Valued
Mar 03Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report
Mar 02We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease
Feb 05The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing
Jan 23What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E
Dec 18These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Nov 21What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?
Nov 06Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Oct 23Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?
Sep 11Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing
Aug 13Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jul 31Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Jul 17Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Jun 07Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
May 01We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Apr 16Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes
Apr 02Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Mar 01Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price
Feb 01Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jan 12Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Dec 29CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$120m |
| Jun 30 2024 | n/a | n/a | US$117m |
| Mar 31 2024 | n/a | n/a | US$102m |
| Dec 31 2023 | US$10m | US$2m | US$94m |
| Sep 30 2023 | n/a | n/a | US$100m |
| Jun 30 2023 | n/a | n/a | US$90m |
| Mar 31 2023 | n/a | n/a | US$85m |
| Dec 31 2022 | US$8m | US$2m | US$75m |
| Sep 30 2022 | n/a | n/a | US$62m |
| Jun 30 2022 | n/a | n/a | US$58m |
| Mar 31 2022 | n/a | n/a | US$48m |
| Dec 31 2021 | US$8m | US$2m | US$48m |
| Sep 30 2021 | n/a | n/a | US$43m |
| Jun 30 2021 | n/a | n/a | US$28m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$8m | US$2m | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$30m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$5m | US$2m | US$5m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$39m |
| Mar 31 2019 | n/a | n/a | US$43m |
| Dec 31 2018 | US$4m | US$2m | US$42m |
| Sep 30 2018 | n/a | n/a | US$40m |
| Jun 30 2018 | n/a | n/a | US$19m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$4m | US$1m | US$28m |
보상 대 시장: Fred 의 총 보상 ($USD 10.05M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 7.94M ).
보상과 수익: Fred 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Fred Lampropoulos (74 yo)
37.3yrs
테뉴어
US$10,052,664
보상
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He is Founder of Merit Medical Systems, Inc. and has been its Chairman and Chief Executive Officer since Jul...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 37.3yrs | US$10.05m | 1.97% $ 119.7m | |
| President | less than a year | US$2.81m | 0.060% $ 3.6m | |
| CFO & Treasurer | 6.5yrs | US$2.77m | 0.020% $ 1.2m | |
| Chief Operating Officer | 2.6yrs | US$2.71m | 0.013% $ 780.7k | |
| Chief Legal Officer & Corporate Secretary | 8.6yrs | US$2.66m | 0.030% $ 1.8m | |
| Chief Information Officer | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Global Communications | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Global Marketing & Strategy | no data | 데이터 없음 | 데이터 없음 | |
| Chief Human Resources Officer | 3.9yrs | 데이터 없음 | 데이터 없음 | |
| Chief Regulatory Affairs Officer | 11.8yrs | 데이터 없음 | 데이터 없음 | |
| Managing Director of Operation Merit Medical Tijuana | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Merit Medical EMEA | no data | 데이터 없음 | 데이터 없음 |
5.2yrs
평균 재임 기간
55.5yo
평균 연령
경험이 풍부한 관리: MMSI 의 관리팀은 노련하고 경험 (평균 재직 기간 5.2 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 37.3yrs | US$10.05m | 1.97% $ 119.7m | |
| Independent Director | 2.5yrs | US$275.99k | 0.0052% $ 317.2k | |
| Lead Independent Director | 9.3yrs | US$320.99k | 0.051% $ 3.1m | |
| Independent Director | 7.5yrs | US$290.99k | 0.029% $ 1.8m | |
| Independent Director | 4.4yrs | US$290.99k | 0.018% $ 1.1m | |
| Independent Director | 5.3yrs | US$295.99k | 0.010% $ 620.5k | |
| Independent Director | 3.4yrs | US$275.99k | 0.0080% $ 488.3k | |
| Independent Director | less than a year | 데이터 없음 | 데이터 없음 |
4.8yrs
평균 재임 기간
63.5yo
평균 연령
경험이 풍부한 이사회: MMSI 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.